Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase
Authors:
- A.G. EllisAEA.G. Ellis
- M.M. DohertyMDM.M. Doherty
- F. WalkerFWF. Walker
- J. WeinstockJWJ. Weinstock
- M. NerrieMNM. Nerrie
- A. VitaliAVA. Vitali
- R. MurphyRMR. Murphy
- T.G. JohnsTJT.G. Johns
- A.M. ScottASA.M. Scott
- A. LevitzkiALA. Levitzki
- G. McLachlanGMG. McLachlan
- L.K. WebsterLWL.K. Webster
- 1 May 2006
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 71 (10) , 1422-1434
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Current Knowledge and Future Directions of the Selective Epidermal Growth Factor Receptor Inhibitors Erlotinib (Tarceva®) and Gefitinib (Iressa®)The Oncologist, 2005
- Structural basis for inhibition of the epidermal growth factor receptor by cetuximabCancer Cell, 2005
- Failing Survival Advantage in Crucial Trial, Future of Iressa Is in JeopardyJNCI: Journal of the National Cancer Institute, 2005
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Epidermal growth factor stimulates proton efflux from chondrocytic cellsJournal of Cellular Physiology, 2002
- Human glioblastoma xenografts overexpressing a tumor-specific mutant epidermal growth factor receptor sensitized to cisplatin by the AG1478 tyrosine kinase inhibitorJournal of Neurosurgery, 2001
- Evaluation of a Sulfobutyl Ether β-Cyclodextrin as a Solubilizing/Stabilizing Agent for Several DrugsDrug Development and Industrial Pharmacy, 1998
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996
- Tyrosine Kinase Inhibition: An Approach to Drug DevelopmentScience, 1995